OTSGC-A24
Sponsors
National University Hospital, Singapore
Conditions
Gastric Cancer
Phase 1
Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer
NCT01227772
Start: 2010-11-30End: 2017-06-30Target: 23Updated: 2016-06-22
Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study.
NCT03784040
Start: 2019-02-21End: 2024-03-01Target: 40Updated: 2019-04-08